avastin (drug)

literal strings: AVASTIN, avastin, AvAstin, Avastin

Help NELL Learn!

NELL wants to know if these beliefs are correct.
If they are or ever were, click thumbs-up. Otherwise, click thumbs-down.

• avastin is a drug     
• avastin is an archaeon     
• avastin is expected to come to market on thursday (dayofweek)     
• avastin is a drug having the side effect side_effects (disease)     
• avastin is a drug that might treat cancer (disease)     
• avastin is a drug that might treat breast_cancer (disease)     

categories

• drug(100.0%)
• SEAL @202 (98.9%) on 09-feb-2011 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ] using avastin
• MBL @1116 (100.0%) on 12-sep-2018 [ Promotion of archaea:avastin drugexpectedreleasedate date:thursday ] using concept:archaea:avastin
• MBL @201 (100.0%) on 09-feb-2011 [ Promotion of archaea:avastin drugexpectedreleasedate date:n2004_02_26 ]
• OE @820 (99.4%) on 06-mar-2014 [   ] using avastin
• CPL @1100 (84.4%) on 30-jan-2018 [ "same period patient was treated with _" "period patient was treated with _" "patient was treated with _" ] using avastin
• Seed
• CMC @853 (100.0%) on 09-jul-2014 [ SUFFIX=in 6.60954 LASTSUFFIX=in 3.33966 SUFFIX=tin 3.08117 PREFIX=ava 2.60316 PREFIX=av 1.62573 CHARS 1.47602 LASTPREFIX=avast 1.24650 FULL_POS=NN -0.65799 SUFFIX=stin -0.78812 WORDS -5.39402 ] using avastin
• product(100.0%)
• CPL @1104 (87.1%) on 18-mar-2018 [ "same period patient was treated with _" "period patient was treated with _" "patient was treated with _" ] using avastin
• SEAL @111 (99.6%) on 02-jun-2010 [ 1 2 3 4 5 6 7 8 ] using avastin
• OE @893 (93.1%) on 30-dec-2014 [ http://topics.nytimes.com/topics/news/health/diseasesconditionsandhealthtopics/avastin_drug/index.html http://en.wikipedia.org/wiki/Bevacizumab http://topics.nytimes.com/topics/news/health/diseasesconditionsandhealthtopics/avastin_drug/index.html http://topics.nytimes.com/topics/news/health/diseasesconditionsandhealthtopics/avastin_drug/index.html http://www.medilexicon.com/drugs/avastin_1039.php http://www.gene.com/patients/medicines/avastin http://topics.nytimes.com/topics/news/health/diseasesconditionsandhealthtopics/avastin_drug/index.html http://topics.nytimes.com/topics/news/health/diseasesconditionsandhealthtopics/avastin_drug/index.html http://topics.nytimes.com/topics/news/health/diseasesconditionsandhealthtopics/avastin_drug/index.html http://www.allaboutvision.com/conditions/lucentis-vs-avastin.htm http://www.cnn.com/2011/HEALTH/06/28/fda.avastin.appeal/index.html http://topics.nytimes.com/topics/news/health/diseasesconditionsandhealthtopics/avastin_drug/index.html http://www.medicalnewstoday.com/articles/255390.php http://www.avastin.com/ http://www.avastin.com/ http://www.avastin.com/ http://www.allaboutvision.com/conditions/lucentis-vs-avastin.htm http://www.gene.com/patients/medicines/avastin http://chemocare.com/chemotherapy/drug-info/avastin.aspx  ] using avastin
• CMC @1045 (100.0%) on 27-mar-2017 [ SUFFIX=in 4.06750 LASTSUFFIX=in 2.42776 SUFFIX=tin 1.50376 LASTSUFFIX=tin 1.42200 LASTPREFIX=ava 1.39985 PREFIX=ava 1.34597 LASTSUFFIX=astin 0.98037 FULL_WORDSHAPE=AaAa -0.12127 SHORT_WORDSHAPE=Aa -0.14894 WORDS -2.87168 ] using avastin
• archaea(98.4%)
• CPL @1098 (98.4%) on 21-jan-2018 [ "you are taking _" "side-effects of _" "side effects from _" "clinical trial of _" "off-label use of _" "FDA approves _" "drugs like _" "treatment with _" "intravitreal injection of _" "tramadol with _" "second dose of _" "dose of _" "side effects of _" "inhibitors such as _" "injections of _" "dosage of _" "injections with _" "therapy with _" "drugs , such as _" "drug called _" "FDA approved _" "drugs such as _" "serious side effects from _" ] using avastin

relations

• drugexpectedreleasedate
• thursday (dayofweek) (100.0%)
• SEAL @628 (100.0%) on 26-aug-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ] using (avastin, thursday)
• Seed
• OE @874 (100.0%) on 21-sep-2014 [ http://articles.washingtonpost.com/2011-12-28/national/35285895_1_ovarian-cancer-national-alliance-avastin-patients-eighth-most-common-cancer  ] using (avastin, thursday)
• drughassideeffect
• side_effects (disease) (98.4%)
• SEAL @521 (87.5%) on 28-feb-2012 [ 1 2 3 ] using (avastin, side_effects)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg2 Additional information References What is arg1" "arg2 are possible with arg1" "arg2 reported with arg1" ] using (avastin, side_effects)
• drugpossiblytreatsphysiologicalcondition
• cancer (disease) (100.0%)
• OE @823 (98.1%) on 17-mar-2014 [   ] using (avastin, cancer)
• CPL @1094 (99.8%) on 01-jan-2018 [ "arg2 medicines like arg1" "arg2 patients treated with arg1" "arg2 patients who took arg1" "arg2 medication called arg1" "arg2 drug called arg1" "arg2 patients taking arg1" "arg2 treatment drug arg1" "arg2 drug known as arg1" "arg2 drugs such as arg1" ] using (avastin, cancer)
• breast_cancer (98.4%)
• CPL @1094 (98.4%) on 01-jan-2018 [ "arg1 is approved to treat arg2" "arg1 as a treatment for metastatic arg2" "arg1 for the treatment of advanced arg2" "arg1 is approved for treating arg2" "arg1 is already approved to treat arg2" "arg1 was approved to treat arg2" ] using (avastin, breast_cancer)
• colorectal_cancer (disease) (98.4%)
• CPL @1094 (98.4%) on 01-jan-2018 [ "arg1 is used to treat metastatic arg2" "arg1 was developed to fight arg2" "arg1 for the treatment of advanced arg2" "arg1 is approved for treating arg2" "arg1 is FDA approved to treat arg2" "arg1 is approved to treat arg2" ] using (avastin, colorectal_cancer)
• drugworkedonbyagent
• genentech (biotechcompany) (100.0%)
• OE @961 (94.0%) on 24-nov-2015 [ http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://en.wikipedia.org/wiki/Bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://blog.seattlepi.com/techchron/2014/09/16/costly-genentech-drug-as-safe-as-cheap-genentech-drug-study-finds/ http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=939b5d1f-9fb2-4499-80ef-0607aa6b114e http://www.nature.com/nbt/journal/v22/n10/full/nbt1004-1198.html http://www.allaboutvision.com/conditions/lucentis-vs-avastin.htm http://blog.seattlepi.com/techchron/2014/09/16/costly-genentech-drug-as-safe-as-cheap-genentech-drug-study-finds/ http://www.avastin.com/  ] using (avastin, genentech)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" "arg1 Manufactured by arg2" ] using (avastin, genentech_inc_)
• CPL @1113 (99.6%) on 03-aug-2018 [ "arg2 had not tested arg1" "arg2 is seeking approval of arg1" "arg2 has no interest in getting arg1" "arg2 received FDA approval for arg1" "arg2 later capped arg1" "arg2 under the trade name arg1" "arg2 under the brand name arg1" "arg2 is the manufacturer of arg1" ] using (avastin, genentech)
• SEAL @295 (96.9%) on 10-jun-2011 [ 1 2 3 4 5 ] using (avastin, genentech)
• roche (company) (99.9%)
• SEAL @269 (98.4%) on 24-may-2011 [ 1 2 3 4 5 6 ] using (avastin, roche)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is marketed by arg2" ] using (avastin, roche)
• OE @821 (86.7%) on 09-mar-2014 [   ] using (avastin, roche)

NELL has only weak evidence for items listed in grey

• drugexpectedreleasedate
• n2004_02_26
• Seed
• drughassideeffect
• stroke (physiologicalcondition)
• CPL @1096 (50.0%) on 18-jan-2018 [ "arg1 causes an increased risk of arg2" ] using (avastin, stroke)
• drugpossiblytreatsphysiologicalcondition
• bowel_cancer (disease)
• CPL @1114 (50.0%) on 18-aug-2018 [ "arg1 is used to treat metastatic arg2" ] using (avastin, bowel_cancer)
• cancer_last_month
• CPL @1096 (50.0%) on 18-jan-2018 [ "arg1 is used for treatment of arg2" ] using (avastin, cancer_last_month)
• colon_cancer (disease)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg1 was originally developed to treat arg2" "arg1 is approved to treat arg2" "arg1 was approved to treat arg2" ] using (avastin, colon_cancer)
• glioblastoma (disease)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 is approved to treat arg2" ] using (avastin, glioblastoma)
• lung_cancer
• CPL @1114 (50.0%) on 18-aug-2018 [ "arg1 Dosage for arg2" ] using (avastin, lung_cancer)
• macular_degeneration (disease)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg1 is sometimes used to treat arg2" "arg1 is not approved to treat arg2" ] using (avastin, macular_degeneration)
• metastatic_breast_cancer
• CPL @1114 (50.0%) on 18-aug-2018 [ "arg1 was approved to treat arg2" ] using (avastin, metastatic_breast_cancer)
• colorectal (physiologicalcondition)
• CPL @1108 (50.0%) on 07-jun-2018 [ "arg1 is approved to treat arg2" ] using (avastin, colorectal)
• drugexpectedreleasedate
• thursday (criminal)
• SEAL @628 (100.0%) on 26-aug-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ] using (avastin, thursday)
• Seed
• OE @874 (100.0%) on 21-sep-2014 [ http://articles.washingtonpost.com/2011-12-28/national/35285895_1_ovarian-cancer-national-alliance-avastin-patients-eighth-most-common-cancer  ] using (avastin, thursday)
• thursday (musicartist)
• SEAL @628 (100.0%) on 26-aug-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ] using (avastin, thursday)
• Seed
• OE @874 (100.0%) on 21-sep-2014 [ http://articles.washingtonpost.com/2011-12-28/national/35285895_1_ovarian-cancer-national-alliance-avastin-patients-eighth-most-common-cancer  ] using (avastin, thursday)
• thursday (televisionshow)
• SEAL @628 (100.0%) on 26-aug-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ] using (avastin, thursday)
• Seed
• OE @874 (100.0%) on 21-sep-2014 [ http://articles.washingtonpost.com/2011-12-28/national/35285895_1_ovarian-cancer-national-alliance-avastin-patients-eighth-most-common-cancer  ] using (avastin, thursday)
• drughassideeffect
• serious_side_effects
• CPL @1103 (50.0%) on 06-mar-2018 [ "arg1 What are the possible arg2" ] using (avastin, serious_side_effects)
• side_effects (bacteria)
• SEAL @521 (87.5%) on 28-feb-2012 [ 1 2 3 ] using (avastin, side_effects)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg2 Additional information References What is arg1" "arg2 are possible with arg1" "arg2 reported with arg1" ] using (avastin, side_effects)
• cases (bedroomitem)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 has been associated with serious arg2" ] using (avastin, cases)
• cases (bodypart)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 has been associated with serious arg2" ] using (avastin, cases)
• cases (clothing)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 has been associated with serious arg2" ] using (avastin, cases)
• cases (consumerelectronicitem)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 has been associated with serious arg2" ] using (avastin, cases)
• cases (crimeorcharge)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 has been associated with serious arg2" ] using (avastin, cases)
• cases (disease)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 has been associated with serious arg2" ] using (avastin, cases)
• cases (geometricshape)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 has been associated with serious arg2" ] using (avastin, cases)
• stroke (hobby)
• CPL @1096 (50.0%) on 18-jan-2018 [ "arg1 causes an increased risk of arg2" ] using (avastin, stroke)
• cases (householditem)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 has been associated with serious arg2" ] using (avastin, cases)
• stroke (medicalprocedure)
• CPL @1096 (50.0%) on 18-jan-2018 [ "arg1 causes an increased risk of arg2" ] using (avastin, stroke)
• cases (mlconference)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 has been associated with serious arg2" ] using (avastin, cases)
• stroke (mountainrange)
• CPL @1096 (50.0%) on 18-jan-2018 [ "arg1 causes an increased risk of arg2" ] using (avastin, stroke)
• cases (nondiseasecondition)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 has been associated with serious arg2" ] using (avastin, cases)
• cases (perceptionaction)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 has been associated with serious arg2" ] using (avastin, cases)
• stroke (perceptionaction)
• CPL @1096 (50.0%) on 18-jan-2018 [ "arg1 causes an increased risk of arg2" ] using (avastin, stroke)
• eye_infections
• CPL @1097 (50.0%) on 19-jan-2018 [ "arg1 might increase the risk of arg2" ] using (avastin, eye_infections)
• stroke (programminglanguage)
• CPL @1096 (50.0%) on 18-jan-2018 [ "arg1 causes an increased risk of arg2" ] using (avastin, stroke)
• cases (sociopolitical)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 has been associated with serious arg2" ] using (avastin, cases)
• cases (software)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 has been associated with serious arg2" ] using (avastin, cases)
• cases (sportsgame)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 has been associated with serious arg2" ] using (avastin, cases)
• half
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 because of its other arg2" ] using (avastin, half)
• cases (tool)
• CPL @1107 (50.0%) on 24-may-2018 [ "arg1 has been associated with serious arg2" ] using (avastin, cases)
• drugpossiblytreatsphysiologicalcondition
• bowel_cancer (agriculturalproduct)
• CPL @1114 (50.0%) on 18-aug-2018 [ "arg1 is used to treat metastatic arg2" ] using (avastin, bowel_cancer)
• colon_cancer (agriculturalproduct)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg1 was originally developed to treat arg2" "arg1 is approved to treat arg2" "arg1 was approved to treat arg2" ] using (avastin, colon_cancer)
• colon_cancer (biotechcompany)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg1 was originally developed to treat arg2" "arg1 is approved to treat arg2" "arg1 was approved to treat arg2" ] using (avastin, colon_cancer)
• colorectal (biotechcompany)
• CPL @1108 (50.0%) on 07-jun-2018 [ "arg1 is approved to treat arg2" ] using (avastin, colorectal)
• counterfeit_cancer
• CPL @1107 (50.0%) on 24-may-2018 [ "arg2 medication called arg1" ] using (avastin, counterfeit_cancer)
• metastatic_colon_cancer
• CPL @1096 (50.0%) on 18-jan-2018 [ "arg1 was approved to treat arg2" ] using (avastin, metastatic_colon_cancer)
• nsclc
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 is also approved to treat arg2" ] using (avastin, nsclc)
• bowel_cancer (medicalprocedure)
• CPL @1114 (50.0%) on 18-aug-2018 [ "arg1 is used to treat metastatic arg2" ] using (avastin, bowel_cancer)
• cancer (medicalprocedure)
• OE @823 (98.1%) on 17-mar-2014 [   ] using (avastin, cancer)
• CPL @1094 (99.8%) on 01-jan-2018 [ "arg2 medicines like arg1" "arg2 patients treated with arg1" "arg2 patients who took arg1" "arg2 medication called arg1" "arg2 drug called arg1" "arg2 patients taking arg1" "arg2 treatment drug arg1" "arg2 drug known as arg1" "arg2 drugs such as arg1" ] using (avastin, cancer)
• colorectal_cancer (medicalprocedure)
• CPL @1094 (98.4%) on 01-jan-2018 [ "arg1 is used to treat metastatic arg2" "arg1 was developed to fight arg2" "arg1 for the treatment of advanced arg2" "arg1 is approved for treating arg2" "arg1 is FDA approved to treat arg2" "arg1 is approved to treat arg2" ] using (avastin, colorectal_cancer)
• macular_degeneration (medicalprocedure)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg1 is sometimes used to treat arg2" "arg1 is not approved to treat arg2" ] using (avastin, macular_degeneration)
• monoclonal_antibody (mollusk)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 drug called arg1" "arg2 drugs such as arg1" ] using (avastin, monoclonal_antibody)
• monoclonal_antibody (physiologicalcondition)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 drug called arg1" "arg2 drugs such as arg1" ] using (avastin, monoclonal_antibody)
• monoclonal_antibody (protein)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 drug called arg1" "arg2 drugs such as arg1" ] using (avastin, monoclonal_antibody)
• glioblastoma (vein)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 is approved to treat arg2" ] using (avastin, glioblastoma)
• glioblastoma (weapon)
• CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 is approved to treat arg2" ] using (avastin, glioblastoma)
• drugworkedonbyagent
• genetech
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 by its manufacturer arg2" ] using (avastin, genetech)
• subsidiary (company)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 is currently manufactured by arg2" ] using (avastin, subsidiary)
• vectibix
• CPL @1108 (50.0%) on 07-jun-2018 [ "arg1 by Genentech and arg2" ] using (avastin, vectibix)
• subsidiary (grandprix)
• CPL @1113 (50.0%) on 03-aug-2018 [ "arg1 is currently manufactured by arg2" ] using (avastin, subsidiary)
• genentech (magazine)
• OE @961 (94.0%) on 24-nov-2015 [ http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://en.wikipedia.org/wiki/Bevacizumab http://www.cancer.gov/cancertopics/druginfo/fda-bevacizumab http://blog.seattlepi.com/techchron/2014/09/16/costly-genentech-drug-as-safe-as-cheap-genentech-drug-study-finds/ http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=939b5d1f-9fb2-4499-80ef-0607aa6b114e http://www.nature.com/nbt/journal/v22/n10/full/nbt1004-1198.html http://www.allaboutvision.com/conditions/lucentis-vs-avastin.htm http://blog.seattlepi.com/techchron/2014/09/16/costly-genentech-drug-as-safe-as-cheap-genentech-drug-study-finds/ http://www.avastin.com/  ] using (avastin, genentech)
• CPL @1113 (99.6%) on 03-aug-2018 [ "arg2 had not tested arg1" "arg2 is seeking approval of arg1" "arg2 has no interest in getting arg1" "arg2 received FDA approval for arg1" "arg2 later capped arg1" "arg2 under the trade name arg1" "arg2 under the brand name arg1" "arg2 is the manufacturer of arg1" ] using (avastin, genentech)
• SEAL @295 (96.9%) on 10-jun-2011 [ 1 2 3 4 5 ] using (avastin, genentech)
• roche (winery)
• SEAL @269 (98.4%) on 24-may-2011 [ 1 2 3 4 5 6 ] using (avastin, roche)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is marketed by arg2" ] using (avastin, roche)
• OE @821 (86.7%) on 09-mar-2014 [   ] using (avastin, roche)